drugset / Trial / NCT05471531
Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine
RandomizedParallel-groupOpen-labelPrevention
Summary
This study is an open-label,single center phase Ⅳ clinical trial of combined immunization with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine.The purpose of this study is to evaluate the safety and immunogenicity of combined immunization with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in the elderly aged 60 years and above.
Timeline
- Start
- 2021-11-13
- Primary completion
- 2022-03-10
- Completion
- 2022-07-10
Outcome
Met primary endpoint
release “四价流感病毒裂解疫苗和23价肺炎球菌多糖疫苗在60岁及以上的老年人群中同时接种的免疫原性非劣效于单独接种” sinovac.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 23-valent pneumococcal polysaccharide vaccine | Vaccine | — | Intramuscular |
| Subject | Quadrivalent influenza vaccine | Vaccine | — | Intramuscular |
Indications
No indication recorded.